Radical metastasectomy followed by sorafenib versus observation in patients withclear cell renal cell carcinoma: extended follow -up of efficacy results from the randomized phase II RESORT trial.
Mennitto A, Verzoni E, Cognetti F, Miceli R, Milella M, Mosca A, Chiuri VE, Bearz A, Morelli F, Ortega C, Atzori F, Donini M, Claps M, Guadalupi V, Sepe P, Cappelletti V, de Braud FG, Procopio G.
Mennitto A, et al. Among authors: procopio g.
Expert Rev Clin Pharmacol. 2021 Feb;14(2):261-268. doi: 10.1080/17512433.2021.1879639. Epub 2021 Jan 31.
Expert Rev Clin Pharmacol. 2021.
PMID: 33472450
Clinical Trial.